These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23112131)

  • 1. Considerations on selected reaction monitoring experiments: implications for the selectivity and accuracy of measurements.
    Domon B
    Proteomics Clin Appl; 2012 Dec; 6(11-12):609-14. PubMed ID: 23112131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of proteins in urine samples using targeted mass spectrometry methods.
    Khristenko N; Domon B
    Methods Mol Biol; 2015; 1243():207-20. PubMed ID: 25384748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of LC-MS/MS analysis: implication for proteomics experiments.
    Gallien S; Duriez E; Demeure K; Domon B
    J Proteomics; 2013 Apr; 81():148-58. PubMed ID: 23159602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving SRM assay development: a global comparison between triple quadrupole, ion trap, and higher energy CID peptide fragmentation spectra.
    de Graaf EL; Altelaar AF; van Breukelen B; Mohammed S; Heck AJ
    J Proteome Res; 2011 Sep; 10(9):4334-41. PubMed ID: 21726076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected reaction monitoring mass spectrometry: a methodology overview.
    Ebhardt HA
    Methods Mol Biol; 2014; 1072():209-22. PubMed ID: 24136525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected reaction monitoring applied to proteomics.
    Gallien S; Duriez E; Domon B
    J Mass Spectrom; 2011 Mar; 46(3):298-312. PubMed ID: 21394846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical considerations for large-scale parallel reaction monitoring analysis.
    Gallien S; Bourmaud A; Kim SY; Domon B
    J Proteomics; 2014 Apr; 100():147-59. PubMed ID: 24200835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in targeted proteomics for clinical applications.
    Domon B; Gallien S
    Proteomics Clin Appl; 2015 Apr; 9(3-4):423-31. PubMed ID: 25504492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly multiplexed targeted proteomics using precise control of peptide retention time.
    Gallien S; Peterman S; Kiyonami R; Souady J; Duriez E; Schoen A; Domon B
    Proteomics; 2012 Apr; 12(8):1122-33. PubMed ID: 22577013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring.
    Law KP; Lim YP
    Expert Rev Proteomics; 2013 Dec; 10(6):551-66. PubMed ID: 24206228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides quantification by liquid chromatography with matrix-assisted laser desorption/ionization and selected reaction monitoring detection.
    Lesur A; Varesio E; Domon B; Hopfgartner G
    J Proteome Res; 2012 Oct; 11(10):4972-82. PubMed ID: 22897511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the ETD/PTR reactions in top-down proteomics as a faster alternative to bottom-up nanoLC-MS/MS protein identification.
    Drabik A; Bodzon-Kulakowska A; Suder P
    J Mass Spectrom; 2012 Oct; 47(10):1347-52. PubMed ID: 23019167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in high-resolution accurate mass spectrometry application to targeted proteomics.
    Lesur A; Domon B
    Proteomics; 2015 Mar; 15(5-6):880-90. PubMed ID: 25546610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How specific is my SRM?: The issue of precursor and product ion redundancy.
    Sherman J; McKay MJ; Ashman K; Molloy MP
    Proteomics; 2009 Mar; 9(5):1120-3. PubMed ID: 19253278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening method using selected reaction monitoring for targeted proteomics studies of nasal lavage fluid.
    Mörtstedt H; Kåredal MH; Jönsson BA; Lindh CH
    J Proteome Res; 2013 Jan; 12(1):234-47. PubMed ID: 23214469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and isoform-specific quantitative assessment of circulating fibulin-1 using selected reaction monitoring MS and time-resolved immunofluorometry.
    Overgaard M; Cangemi C; Jensen ML; Argraves WS; Rasmussen LM
    Proteomics Clin Appl; 2015 Aug; 9(7-8):767-75. PubMed ID: 25331251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS.
    Liu Y; Hüttenhain R; Surinova S; Gillet LC; Mouritsen J; Brunner R; Navarro P; Aebersold R
    Proteomics; 2013 Apr; 13(8):1247-56. PubMed ID: 23322582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry.
    Rauniyar N
    Int J Mol Sci; 2015 Dec; 16(12):28566-81. PubMed ID: 26633379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.
    Prakash A; Rezai T; Krastins B; Sarracino D; Athanas M; Russo P; Ross MM; Zhang H; Tian Y; Kulasingam V; Drabovich AP; Smith C; Batruch I; Liotta L; Petricoin E; Diamandis EP; Chan DW; Lopez MF
    J Proteome Res; 2010 Dec; 9(12):6678-88. PubMed ID: 20945832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery.
    Elschenbroich S; Kislinger T
    Mol Biosyst; 2011 Feb; 7(2):292-303. PubMed ID: 20976349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.